# Yaron Breski

> Yaron Breski is a Series B investor at RM Global Partners backing Health Care. See 1 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: Angel Investor
- Fund: [RM Global Partners](https://shizune.co/investors/profile/rm-global-partners)
- Total investments: 1
- Last investment: Feb 2019
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/yaronbreski

Yaron Breski is a Series B investor at RM Global Partners focused on Health Care and Therapeutics. Yaron Breski is the Managing Director at RM Global Partners. Yaron holds a Bachelor of Science in Biology, Magna Cum Laude, exclusive research track for honors students from the Tel Aviv University; and a Masters of Business Administration from The Wharton School, University of Pennsylvania.

## Contacts

5 contacts available for Yaron Breski: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/yaron-breski?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 1 | 100% |
| Therapeutics | 1 | 100% |
| Biotechnology | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| BIOMx | BiomX discovers and develops innovative microbiome therapeutics. The Company's mission is to develop novel therapeutics for preventing and treating diseases in which microbiome imbalances have been implicated. BiomX's microbiome modulation technologies are based on the cutting-edge innovative research of its scientific collaborators:Professor Rotem Sorek, PhD and Dr. Eran Elinav, MD, PhD both of the Weizmann Institute of Science and Professor Timothy K. Lu, MD, PhD of the Massachusetts Institute of Technology. | $32M | Series B | Feb 20, 2019 | http://biomx.com |

1 of 1 investments shown.

## Co-investors
- [Chong Kun Dang Pharmaceutical Corp.](https://shizune.co/investors/profile/chong-kun-dang-pharmaceutical-corp) — VC Fund, 1 deal together
- [Consensus Business Group](https://shizune.co/investors/profile/consensus-business-group) — VC Fund, 1 deal together
- [Handok](https://shizune.co/investors/profile/handok) — VC Fund, 1 deal together
- [Johnson & Johnson Robotics and Digital Solutions](https://shizune.co/investors/profile/johnson-johnson-innovation) — VC Fund, 1 deal together
- [KB Investment](https://shizune.co/investors/profile/kbinvest) — VC Fund, 1 deal together
- [Mirae Asset Capital](https://shizune.co/investors/profile/mirae-asset-capital) — VC Fund, 1 deal together

## About RM Global Partners

VC Fund · New York, United States

RM Global is an investment banking and strategic advisory firm dedicated to creating unique value for its clients and investors. We specialize in Life Sciences, including pharmaceuticals, medical devices, biotechnology, healthcare IT/digital health, and diagnostics. Our broad international reach includes the Americas, Europe, Israel, and Asia.Since 1992, our diverse team of accomplished professionals has worked closely with life science companies ranging from start-ups to multinationals, providing unbiased strategic and financial advice, based upon our comprehensive industry experience. Several of our partners were senior management of Roberts Mitani, which completed over $3 billion in M&A and strategic transactions and raised over $200 million in private growth and venture capital for clients. We take pride in our long term relationships with our clients that span many years.We leverage our unique global network of leading corporations, investment funds, institutional and strategic investors, family offices, industry experts and management teams to source and execute transactions that build new opportunities for our clients worldwide.

3 contacts available at RM Global Partners.

| Name | Title | Profile |
| --- | --- | --- |
| Bruce E. Roberts | Managing Director | https://shizune.co/investors/profile/bruce-e-roberts-2 |
| Lisa Wisniewski | Managing Director | https://shizune.co/investors/profile/lisa-wisniewski-f51f |
| Yaron Breski | Managing Director | https://shizune.co/investors/profile/yaron-breski |

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Yaron Breski invest in?

Yaron Breski invests primarily in Health Care, Therapeutics and Biotechnology startups, most often at Series B stage. Most of the 1 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Yaron Breski?

Public channels for Yaron Breski include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Yaron Breski last invest?

The most recent investment recorded for Yaron Breski closed in Feb 2019. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co